EPR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.426000E-01
Normal-vs-Stage2
3.447800E-01
Normal-vs-Stage3
3.132000E-01
Normal-vs-Stage4
8.995800E-01
Stage1-vs-Stage2
3.714400E-01
Stage1-vs-Stage3
4.941400E-01
Stage1-vs-Stage4
6.635600E-01
Stage2-vs-Stage3
8.861200E-01
Stage2-vs-Stage4
3.015800E-01
Stage3-vs-Stage4
2.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.802800E-01
Normal-vs-AfricanAmerican
3.942000E-01
Normal-vs-Asian
2.890400E-01
Caucasian-vs-AfricanAmerican
9.374400E-01
Caucasian-vs-Asian
7.622200E-01
AfricanAmerican-vs-Asian
7.517600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.007600E-01
Normal-vs-Female
3.536000E-01
Male-vs-Female
2.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.743400E-01
Normal-vs-Age(41-60Yrs)
3.868000E-01
Normal-vs-Age(61-80Yrs)
3.833600E-01
Normal-vs-Age(81-100Yrs)
1.773010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.986400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.979000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.124400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.599000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.744600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.276200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.279200E-01
Normal-vs-Daily Drinker
3.493000E-01
Normal-vs-Weekly Drinker
1.228630E-01
Normal-vs-Occasional Drinker
3.547000E-01
Normal-vs-Social Drinker
2.359400E-01
Non Drinker-vs-Daily Drinker
7.641600E-01
Non Drinker-vs-Weekly Drinker
4.933000E-01
Non Drinker-vs-Occasional Drinker
6.762200E-01
Non Drinker-vs-Social Drinker
7.785200E-01
Daily Drinker-vs-Weekly Drinker
4.037600E-01
Daily Drinker-vs-Occasional Drinker
4.713600E-01
Daily Drinker-vs-Social Drinker
5.172600E-01
Weekly Drinker-vs-Occasional Drinker
6.656800E-01
Weekly Drinker-vs-Social Drinker
5.947400E-01
Occasional Drinker-vs-Social Drinker
8.894000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.329400E-01
Normal-vs-Grade 2
5.764800E-01
Normal-vs-Grade 3
5.946200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.228300E-04
Grade 1-vs-Grade 3
2.230300E-04
Grade 1-vs-Grade 4
5.329400E-01
Grade 2-vs-Grade 3
2.603200E-01
Grade 2-vs-Grade 4
5.764800E-01
Grade 3-vs-Grade 4
5.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.663600E-01
Normal-vs-NonDiabetic
3.647800E-01
Diabetic-vs-NonDiabetic
7.620400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.329180E-01
Normal-vs-NoPancreatitis
4.190800E-01
Pancreatitis-vs-NoPancreatitis
4.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.457000E-01
Normal-vs-N1
3.731000E-01
N0-vs-N1
7.699800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.68820000000714E-05
Normal-vs-TP53-NonMutant
4.805700E-02
TP53-Mutant-vs-TP53-NonMutant
3.047300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
